QA: Verastem Inc. in us_pharma/2021

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001526119_2022_Verastem_Inc.pdf

Logs

Graph

Absolute values for 0001526119, Verastem Inc.

  xvar xval
0 AssetsCurrent 105,740,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 210,000
3 remainder_Assets 2,712,000
4 LiabilitiesCurrent 18,590,000
5 LiabilitiesNoncurrent 2,264,000
6 remainder_Liabilities 249,000
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 24,115,000
9 ResearchAndDevelopmentExpense 39,347,000
10 remainder_Expenses 9,972,000
11 remainder_Revenues 2,053,000
12 remainder_NetIncome 181,000
13 remainder_ComprehensiveNetIncome -19,000
  yvar yval
0 Assets 108,662,000
1 Liabilities 21,103,000
2 Expenses 73,434,000
3 Revenues 2,053,000
4 StockholdersEquity 87,559,000
5 NetIncome -71,200,000
6 ComprehensiveNetIncome -71,209,500
7 BaseVar 102,726,000
8 EconomicCapitalRatio 1.22

Edgar->Model Mapping

Feature Distribution

Change over Time